跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
SKYRIZI 180 MG SOLUCION INYECTABLE EN CARTUCHO
Approved
STANDARD
SKYRIZI 180 MG SOLUCION INYECTABLE EN CARTUCHO
Abbvie Deutschland Gmbh & Co. Kg
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 1, 2024
Approval ID
b9f026197f6e3232
Company
Abbvie Deutschland Gmbh & Co. Kg
Type
Standard
Approval Details
Approval Id
b9f026197f6e3232
Drug Cima Aemps Name
SKYRIZI 180 MG SOLUCION INYECTABLE EN CARTUCHO
Register Number
1191361007
Holder Company Name
Abbvie Deutschland Gmbh & Co. Kg
Marketing Company Name
Abbvie Spain, S.L.U.
Holder Company Detail Path
/organization/abbvie-deutschland-gmbh-and-co-kg
Authorization Date
2024-08-01
Dosage Form
SOLUCIÓN INYECTABLE EN CARTUCHO
Dose
180 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Abbvie Deutschland Gmbh & Co. Kg
Company Detail Path
/organization/abbvie-deutschland-gmbh-and-co-kg
Company Information
Pharmaceutical Company Name
AbbVie Deutschland GmbH & Co. KG
Country Name
Germany
City Name
ludwigshafen am rhein,rheinland-pfalz,country_de
Address
Knollstr. 50
Website
http://www.abbvie.de
Active Ingredients
RISANKIZUMAB
180 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 1, 2024
Approval ID
b9f026197f6e3232
Type
Standard
Back to CIMA-AEMPS Approvals
SKYRIZI 180 MG SOLUCION INYECTABLE EN CARTUCHO - CIMA-AEMPS Drug Approval Details
